Showing results (41-50 of 195) with videos related to
Sort By:
Pageof 20
European Heart Journal. Cardiovascular Pharmacotherapy|October 16, 2020
Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trialsAnna Plitt, Thomas A Zelniker, Jeong-Gun Park, et al.Hypertension (Dallas, Tex. : 1979)|July 30, 2019
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 TrialSungha Park, Brian A Bergmark, Minggao Shi, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 24, 2016
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic SubstudyDeepak K Gupta, Robert P Giugliano, Christian T Ruff, et al.European Heart Journal|December 28, 2018
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trialTze-Fan Chao, Shih-Ann Chen, Christian T Ruff, et al.JAMA Cardiology|October 6, 2016
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.Journal of the American College of Cardiology|March 5, 2021
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial FibrillationJan Steffel, Christian T Ruff, Ophelia Yin, et al.Clinical Cardiology|January 24, 2014
Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain studyDevraj Sukul, Marc P Bonaca, Christian T Ruff, et al.American Heart Journal|December 19, 2015
Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trialElizabeth A Magnuson, Katherine Vilain, Kaijun Wang, et al.American Heart Journal|September 21, 2015
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trialBram J Geller, Robert P Giugliano, Eugene Braunwald, et al.Journal of the American Heart Association|February 25, 2016
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 TrialHaiyan Xu, Christian T Ruff, Robert P Giugliano, et al.Pageof 20